Surmodics (NASDAQ:SRDX) Upgraded at Lake Street Capital
Lake Street Capital upgraded shares of Surmodics (NASDAQ:SRDX – Free Report) from a hold rating to a buy rating in a report published on Friday morning, Marketbeat.com reports. Lake Street Capital currently has $43.00 price target on the stock. Several other equities research analysts have also recently commented on SRDX. StockNews.com started coverage on shares […]
